Kawamoto, H.; Hara, H.; Araya, J.; Ichikawa, A.; Fujita, Y.; Utsumi, H.; Hashimoto, M.; Wakui, H.; Minagawa, S.; Numata, T.;
et al. Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma. Cancers 2019, 11, 768.
https://doi.org/10.3390/cancers11060768
AMA Style
Kawamoto H, Hara H, Araya J, Ichikawa A, Fujita Y, Utsumi H, Hashimoto M, Wakui H, Minagawa S, Numata T,
et al. Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma. Cancers. 2019; 11(6):768.
https://doi.org/10.3390/cancers11060768
Chicago/Turabian Style
Kawamoto, Hironori, Hiromichi Hara, Jun Araya, Akihiro Ichikawa, Yu Fujita, Hirofumi Utsumi, Mitsuo Hashimoto, Hiroshi Wakui, Shunsuke Minagawa, Takanori Numata,
and et al. 2019. "Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma" Cancers 11, no. 6: 768.
https://doi.org/10.3390/cancers11060768
APA Style
Kawamoto, H., Hara, H., Araya, J., Ichikawa, A., Fujita, Y., Utsumi, H., Hashimoto, M., Wakui, H., Minagawa, S., Numata, T., Arihiro, S., Matsuura, T., Fujiwara, M., Ito, S., & Kuwano, K.
(2019). Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma. Cancers, 11(6), 768.
https://doi.org/10.3390/cancers11060768